Xiao Jiayu, Padrick Matthew M, Song Shlee S, Fan Zhaoyang, Schlick Konrad H
Departments of Radiology, Keck School of Medicine of USC, Los Angeles, CA, United States.
Biomedical Imaging Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Front Neurosci. 2021 Oct 20;15:739178. doi: 10.3389/fnins.2021.739178. eCollection 2021.
Intracranial atherosclerotic disease (ICAD) is a dynamic process that leads to ischemic stroke. Symptomatic ICAD patients still suffer a high recurrent rate even under standard treatment. In this case report, to better understand the response of intracranial atherosclerotic plaques to medication, serial MR imaging was added to standard clinical workup in a 47-year-old male patient with acute occipital lobe infarction at baseline, 3-month, 6-month, and 12-month post index stroke to directly visualize the morphology and signal change of plaques. We noticed that one of the plaques showed dramatic worsening at 3-month imaging follow-up despite a decrease in low-density lipoprotein level. Early identification of patients who do not respond well to medication is critical to prevent the recurrence of cardiovascular events in ICAD patients.
颅内动脉粥样硬化疾病(ICAD)是一个导致缺血性中风的动态过程。即使在标准治疗下,有症状的ICAD患者仍有较高的复发率。在本病例报告中,为了更好地了解颅内动脉粥样硬化斑块对药物治疗的反应,在一名基线时患有急性枕叶梗死的47岁男性患者中,于首次中风后的3个月、6个月和12个月,在标准临床检查中增加了系列磁共振成像,以直接观察斑块的形态和信号变化。我们注意到,尽管低密度脂蛋白水平有所下降,但在3个月的影像学随访中,其中一个斑块显示出显著恶化。早期识别对药物治疗反应不佳的患者对于预防ICAD患者心血管事件的复发至关重要。